These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

122 related items for PubMed ID: 7993841

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. A four-drug combination chemotherapy with cisplatin, mitomycin, vindesine and 5 fluorouracile: a regimen associated with major toxicity in patients with advanced non-small cell lung cancer.
    Klastersky J, Sculier JP, Ries F, Dabouis G, Libert P, Schmerber J, Thiriaux J, Berchier MC, Bureau G, Van Cutsem O.
    Lung Cancer; 1994 Dec; 11(5-6):373-84. PubMed ID: 7704494
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. [A randomized trial comparing vindesine plus cisplatin with mitomycin C, vindesine plus cisplatin in patients with advanced non-small cell lung cancer].
    Fujii M, Kiura K, Okabe K, Toki H, Kimura M.
    Gan To Kagaku Ryoho; 1987 Sep; 14(9):2676-81. PubMed ID: 2820312
    [Abstract] [Full Text] [Related]

  • 6. Phase II study of concurrent radiotherapy and chemotherapy for unresectable stage III non-small-cell lung cancer. Southern Osaka Lung Cancer Study Group.
    Furuse K, Kubota K, Kawahara M, Kodama N, Ogawara M, Akira M, Nakajima S, Takada M, Kusunoki Y, Negoro S.
    J Clin Oncol; 1995 Apr; 13(4):869-75. PubMed ID: 7707113
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. A randomised clinical trial of vindesine plus cisplatin versus mitomycin plus vindesine and cisplatin in advanced non-small cell lung cancer.
    Shinkai T, Eguchi K, Sasaki Y, Tamura T, Ohe Y, Kojima A, Oshita F, Saijo N.
    Eur J Cancer; 1991 Apr; 27(5):571-5. PubMed ID: 1647183
    [Abstract] [Full Text] [Related]

  • 9. Multicenter randomized trial comparing cisplatin-mitomycin-vinorelbine versus cisplatin-mitomycin-vindesine in advanced non-small cell lung cancer. 'Groupe Français de Pneumo-Cancérologie'.
    Pérol M, Guérin JC, Thomas P, Poirier R, Carles P, Robinet G, Kleisbauer JP, Paillotin D, Vergnenègre A, Balmes P, Touron D, Grivaux M, Pham E.
    Lung Cancer; 1996 Feb; 14(1):119-34. PubMed ID: 8696715
    [Abstract] [Full Text] [Related]

  • 10. Cisplatin, vindesine, mitomycin-C and 13-cis retinoic acid in the treatment of advanced non small cell lung cancer. A phase II pilot study.
    Recchia F, Sica G, De Filippis S, Rosselli M, Saggio G, Guerriero G, Pompili P, Rea S.
    Anticancer Res; 2000 Feb; 20(3B):1985-90. PubMed ID: 10928138
    [Abstract] [Full Text] [Related]

  • 11. A weekly cisplatin-based induction regimen for extensive non-small cell lung cancer. A Southwest Oncology Group study.
    Higano CS, Crowley J, Livingston RB, Goodwin JW, Barlogie B, Stuckey WJ.
    Cancer; 1991 May 15; 67(10):2439-42. PubMed ID: 1849785
    [Abstract] [Full Text] [Related]

  • 12. Combined chemotherapy and differentiation therapy in the treatment of advanced non-small-cell lung cancer.
    Recchia F, Sica G, De Filippis S, Rea S, Frati L.
    Anticancer Res; 1997 May 15; 17(5B):3761-5. PubMed ID: 9427776
    [Abstract] [Full Text] [Related]

  • 13. Combination chemotherapy with vindesine-ifosfamide-cisplatin (VIP) in locally advanced unresectable stage III and in stage IV non-small cell lung cancer: a phase II trial.
    Vansteenkiste J, Vandebroek J, Mariën S, Roex L, Bertrand P, Bockaert J, De Beukelaar T, Deman R, De Muynck P, Ulrichts H.
    Lung Cancer; 1995 Dec 15; 13(3):295-303. PubMed ID: 8719069
    [Abstract] [Full Text] [Related]

  • 14. Phase III trial with and without lonidamine in non-small cell lung cancer.
    Gatzemeier U, Cavalli F, Häussinger K, Kaukel E, Koschel G, Martinelli G, Neuhauss R, von Pawel J.
    Semin Oncol; 1991 Apr 15; 18(2 Suppl 4):42-8. PubMed ID: 1851577
    [Abstract] [Full Text] [Related]

  • 15. [Prognostic factors affecting survival and response in patients with advanced non-small cell lung cancer treated with combination chemotherapy].
    Takifuji N, Fukuoka M, Negoro S, Takada M, Kusunoki Y, Matsui K, Masuda N, Ryu S, Sakai N, Kubota K.
    Gan To Kagaku Ryoho; 1990 Mar 15; 17(3 Pt 2):429-34. PubMed ID: 2157364
    [Abstract] [Full Text] [Related]

  • 16. Superiority of three-drug combination chemotherapy versus cisplatin-etoposide in advanced non-small cell lung cancer: a randomized trial by the Italian Oncology Group for Clinical Research.
    Crinò L, Clerici M, Figoli F, Barduagni M, Carlini P, Ceci G, Cortesi E, Carpi A, Santini A, Di Costanzo F.
    Lung Cancer; 1995 Apr 15; 12 Suppl 1():S125-32. PubMed ID: 7551920
    [Abstract] [Full Text] [Related]

  • 17. Combination chemotherapy with mitomycin, vindesine, and cisplatin for non-small cell lung cancer. Association of antitumor activity with initial tumor burden and treatment center.
    Joss RA, Bürki K, Dalquen P, Schatzmann E, Leyvraz S, Cavalli F, Ludwig C, Siegenthaler P, Alberto P, Stahel R.
    Cancer; 1990 Jun 01; 65(11):2426-34. PubMed ID: 2159837
    [Abstract] [Full Text] [Related]

  • 18. Comparison of cisplatin plus vindesine with cisplatin plus mitomycin C for treatment of advanced non-small-cell lung cancer. The Eastern Shikoku Lung Cancer Chemotherapy Group.
    Shimizu E, Ogura T, Sone S, Nakayama T, Doi H, Takishita Y, Bando H, Kobayashi M, Kimura K, Sasaki H.
    Oncology; 1993 Jun 01; 50(1):5-9. PubMed ID: 8380634
    [Abstract] [Full Text] [Related]

  • 19. Random prospective study of vindesine versus vindesine plus high-dose cisplatin versus vindesine plus cisplatin plus mitomycin C in advanced non-small-cell lung cancer.
    Einhorn LH, Loehrer PJ, Williams SD, Meyers S, Gabrys T, Nattan SR, Woodburn R, Drasga R, Songer J, Fisher W.
    J Clin Oncol; 1986 Jul 01; 4(7):1037-43. PubMed ID: 3088219
    [Abstract] [Full Text] [Related]

  • 20. Cisplatin, vindesine, and 96-h continuous infusion of 5-fluorouracil as initial chemotherapy for locally advanced head and neck carcinoma.
    Perey L, Pasche P, Bauer J, Capasso P, Savary M, Leyvraz S.
    Am J Clin Oncol; 1991 Apr 01; 14(2):162-5. PubMed ID: 2028924
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.